In hepatocellular carcinoma, the activation of the CXCL12/CXCR4 axis via the STAT3 signaling pathway promotes protein expression of CSC markers SOX2 and CD133, enhancing the spheroid-forming capacity and invasiveness of liver cancer cells [91]. Here, STAT3 is linked to hepatocellular carcinoma.